Computational Modeling and Evaluation of Potential mRNA and Peptide-Based Vaccine against Marburg Virus (MARV) to Provide Immune Protection against Hemorrhagic Fever

A hemorrhagic fever caused by the Marburg virus (MARV) belongs to the Filoviridae family and has been classified as a risk group 4 pathogen. To this day, there are no approved effective vaccinations or medications available to prevent or treat MARV infections. Reverse vaccinology-based approach was...

Descripción completa

Detalles Bibliográficos
Autores principales: Albaqami, Faisal F., Altharawi, Ali, Althurwi, Hassan N., Alharthy, Khalid M., Qasim, Muhammad, Muhseen, Ziyad Tariq, Tahir ul Qamar, Muhammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10125739/
https://www.ncbi.nlm.nih.gov/pubmed/37101690
http://dx.doi.org/10.1155/2023/5560605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10125739/
https://www.ncbi.nlm.nih.gov/pubmed/37101690
http://dx.doi.org/10.1155/2023/5560605

Ejemplares similares